Updated
Updated · KSL.com · Oct 2
Medical Groups Issue 2026-27 Flu, COVID, RSV Vaccine Advice for 3 Viruses as CDC Sticks to Last Year
Updated
Updated · KSL.com · Oct 2

Medical Groups Issue 2026-27 Flu, COVID, RSV Vaccine Advice for 3 Viruses as CDC Sticks to Last Year

3 articles · Updated · KSL.com · Oct 2

Summary

  • Several U.S. medical groups released 2026-27 recommendations for flu, COVID-19 and RSV shots as the respiratory virus season begins and vaccines reach pharmacies nationwide.
  • The guidance leans on independent reviews published in JAMA after CDC upheaval and lawsuits left the agency posting advice that largely follows last year's flu and COVID recommendations.
  • RSV advice targets adults 75 and older, people 50 and older with high-risk conditions, pregnant people at 32 to 36 weeks, and infants under 8 months via monoclonal antibody if maternal vaccination was not given.
  • Flu vaccination is recommended annually for everyone 6 months and older, ideally in October; adults 65 and older should get enhanced shots, and a new mRNA flu vaccine is available for adults 50 and older.
  • Updated COVID-19 shots are recommended for all adults, with a second dose after 6 months for those 65 and older, as flu activity remains low nationally but some Western indicators are already rising.

Insights

RSV hospitalizes millions of infants globally, but will the newest maternal vaccines and antibody treatments be enough to stop this silent threat?
Health officials urge October vaccinations, but what happens if our immunity fades before the winter virus surge truly hits?
With a groundbreaking mRNA flu vaccine now available, could this new technology finally outsmart the unpredictable winter respiratory season?